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On June 3 & 4,
the Board held
its first retreat since September 1992.
The participants were expanded to
include Senior Administration, all
Clinical Chairs, and TROIKA
(collectively, the Senior Management
Council). The purpose of this retreat
centered on three concepts: (1)
Functional Plan, (2) Governance, and
(3) Physician Practice Organizations.

The Functional Plan addressed short
term and long-range plans for Lehigh
Valley Health Network. Immediate
projects include the acute inpatient
consolidation at Cedar Crest, outpatient
surgery, Fast Track E.R., OB services,
etc. Concurrently planning on future
programs and operational requirements
involving the downsizing of the
inpatient hospital and developing
ambulatory requirements; ultimately, a
complete master facility plan to address
our long-term needs are included in the
functional planning process. The
Board will further address the
functional plan at its July meeting.
The second topic of Governance
addressed the clarification of Board:
Senior Management Council roles.
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Established was the authority and
responsibility of the CEO and Senior
Management Council for management
decisions. The Board of Trustees have
the ultimate authority for the
governance of the network and its
divisions. Medical Executive
Committee will continue its
authority/responsibility for quality
assurance and credentials, answering to
the Q.A./Staff Development Committee
9f the Board of Trustees and to the
Board of Trustees.
Joe Lyons, Executive Director of
Lehigh Valley Physician Group,
presented details of the physician group
followed by John VanBrakle's eloquent
review of the pediatric physicians
group, detailing that department's
organization and plans. Finally, I
presented the practice model
represented by the majority of the
medical staff. Healthy discussion
ensued with the realization that
different physician organizations will
be part of the Lehigh Valley Health
Network.
I would encourage all members of our
medical staff to further review these
topics with their department chairs and
TROIKA. For more details about the
retreat, refer to pages 4 and 5 of the
newsletter.
Continued on Page 2
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We welcome Richard Boorse, Paul
Guillard, James Jaffe, and Jay
Kaufman to the Medical Executive
Committee and anticipate their
contributions. A special Thank You to
Carl D'Angelo, Mark Gittleman, Glenn
Kratzer, Joe Gastinger, and Jim
Goodreau for their dedication and
service to the medical staff as members
of Medical Executive Committee.
I will update the search committees in
the next newsletter, but one search has
been completed. The COO search
committee has completed its work and
Elliot has hired Lou Liebhaber as 'our
new COO. Lou comes from Mt. Sinai
in New York where he has enjoyed
success in hospital administration in
working with a very large medical staff
of multiple practice organizations.

Also, Jim Burke has been hired as the
Vice President for Site Operations at
17th &. Chew. Jim is from the
Hospital of the University of
Pennsylvania and also should represent
a wonderful addition. Jim of course
'
'
will be involved in the development of
the ambulatory/surgical services and
will be seeking our input. Please make
him and Lou (due to start in July)
welcome.
A final note, please return the PHO
survey information and be a candidate
to spend a weekend in Bermuda.

Wishing all a great summer.

11-

Candio, M.D.
President, Medical Staff

Site· and Facilities Update
17th & Chew
Renovations to Begin for Ambulatory
Surgery
Renovations to the second floor tower
will begin in late June for an
ambulatory surgery suite that will
adjoin the Operating Room suites.

Later this month, renovations will
begin on 3T, the area now occupied by
the Mother/Baby Unit, for 10 new
labor/Delivery/Recovery (LDR)
rooms. Subsequently, the existing
labor and Delivery Unit will be
~sformed into a high-risk antepartum
umt for mothers who require
hospitalization during pregnancy.

General Upgrades

Open House Planned for
Mother/Baby Unit
The Mother/Baby Unit will relocate to
newly-renovated quarters on 4T in mid
June. The new unit will accommodate
postpartum mothers and their babies in
predominantly single rooms with
private bath facilities.

Electrical, plumbing and other
upgrades to the hospital infrastructure
on the second to sixth floor, T wing
are scheduled to be completed this
month.
Continued on Page 3
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Rehabilitative Services to Relocate
Physical and occupational therapy will
relocate to the fifth floor tower in late
June, following inspection by the
Division of Hospitals and the Life
Safety Division of the State
Department of Health. These
rehabilitative services will adjoin the
transitional, or sub-acute care unit now
under review by the Pennsylvania
Department of Health.
Outpatient Treatment Unit Relocates
The Outpatient Treatment Unit has
expanded from eight to twelve bays at
its new location on 4N.

Cedar Crest & 1-78
Renovations Proceedin& for
ExpressCare
Renovations are proceeding on
schedule in the former offices of
Medical Staff Services which will be
converted into a four-bay treatment
area for ExpressCare, emergency
treatment for minor illness or injury.
The new treatment setting will adjoin
the patient registration area in the
Emergency Department. Expresscare
is scheduled to be available on July 1.

offices on the fourth floor of the John
and Dorothy Morgan Cancer Center, in
accordance with the hospital's original
plans for the facility. In addition, ~ew
physician offices will occupy the third
floor of the Cancer Center. The
offices will be ready for occupancy in
early August. Eventually, the Cancer
Center will house many of the
departments which now occupy the
trailers as well as other consolidated
departments.
Administrative Services Relocation
Administrative offices adjacent to the
lobby will be relocated to an
administrative suite for senior
management on the third floor of the
Anderson Wing. The administrative
suite is now under construction and
scheduled for completion in mid-July.
The Board of Trustees conference
room will be relocated to this area as
well.
Physical Therapy/Occupational
Therapy and Cardiac Cath Lab
Renovations to the physical and
occupational therapy departments and
cardiac cath lab No. 3 have been
completed.

Fourth Floor of Cancer Center to
House Offices
Human Resources, Legal Services/Risk
Management, IntegrcLted Quality
Assessment/Resource Utilization
Management (IQA/RUM), the
Information Services Training Room,
and the Credit Union will occupy new
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Trustees, Leadership Retreat Held·
Lehigh Valley Hospital Trustees, the
Pool Health Care Trustees and the
Senior Management Council, which
includes members of TROIKA, 12
Department Chairs, and Senior
Administration, participated in a retreat
held on Friday, June 3 and Saturday,
June 4 at the Holiday Inn in
Fogelsville.
The meeting focused on the review of
three major initiatives, a decision
making matrix which defined the role
and responsibilities of the Board of
Trustees and Senior Management,
recommendations from the functional
planning process, and the status of the
Physician Hospital Organization and its
related entities.
A decision making matrix, which will
be distributed to all physicians and
staff, defined the decision making
relationship and responsibilities
between the Board of Trustees, the
Chief Executive Officer and Senior
Management Council.
It was unanimously agreed that while
the Board would continue its role in
governance, i.e., setting the broad
direction for the organization and
setting policy, the responsibility for
recommending and managing policy
development, strategy and tactics to
achieve specific goals and operations
would be the responsibility of the Chief
Executive Officer and the members of
the Senior Management Council.

The matrix will clarify for the medical
staff and management at Lehigh Valley
Hospital and its operating divisions the
process by which decisions are

reviewed and acted upon. Members o..
the medical staff will receive this
material as soon as it receives final
review at Senior Management Council.
The second major topic reviewed the
preliminary recommendations of the
10-month functional planning process
which began last August when the firm
of Hamilton/KSA of Virginia was
engaged- to assist Senior Management
with the development of a functional
plan. The plan would determine the
scope and range of services Lehigh
Valley Hospital could expect to provide
over the next 10 years and the type of
facilities which would be needed to
accommodate those services.
The major recommendations called for
the redesign of the process by which
both out-patient and inpatient services
are delivered. Service delivery will bt.
driven by a concept called "The Ideal
Patient Encounter" which attempts to
maximize convenience to the patient
and maximize the clinical encounter.
It is believed that through this service
delivery redesign, the hospital and its
medical staff will achieve operating
efficiencies critical to remaining
competitive in health services delivery
-- efficiencies driven by the need to
reduce costs and improve service
delivery in the light of increasing
pressures from purchasers of health
services, i.e., managed care
companies, insurers, business and
industry, and government purchasers of
care.
Continued on Page 5
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The plan also outlined the needs to add
additional square footage at the Cedar
Crest site not only for redesigned
outpatient services but for the final
consolidation of OB/GYN and Mental
Health Services, and the return of
ambulatory surgery to Cedar Crest.
Tentative plans call for the additional
construction of approximately 150,000
square feet for ambulatory diagnostics,
ambulatory surgery, emergency and
diagnostic center growth and the
relocation of Women's and Mental
Health Services. An additional
renovation of 58,000 square feet was
recommended for emergency and
diagnostics, a patient access center,
cardiac diagnostics and
angiography/CT suites.
Several levels of underground parking
were also recommended in a footprint
that would extend out from the
northeast comer of the hospital and up
to but not including the 1210 building.
Total project cost of this next phase of
construction, expected to be completed
in 1997/98, is currently estimated to be
$58 million. It has previously been
estimated that annual operating
efficiencies achieved by the complete
inpatient consolidation could be in the
range of $28 million.

better position the organization to
respond to the changes brought on by
managed care. They also learned of
other activity in the service area by
various physician groups and hospitals
in response to the changing market.
The meeting closed with a discussion
of loyalty between the Board and the
medical staff and concluded that a
statement from the Board outlining its
expectations of the medical staff and
the expectation medical staff members
could have of the Board, should be
developed.
The next steps in this process will
involve review of the functional .
planning recommendations at the July
6 Board of Trustees meeting,
distribution of the decision making
matrix to physicians and management
and further development of the PHO.
All medical staff members are
encouraged to direct any questions to
members of the Senior Management
Council who represent your specialty
or plan to attend your regularly
_scheduled department meetings.

Discussion on Saturday morning
provided attendees with an update of
the Physician Hospital Organization
and several of its components, the
Independent Practice Organization and
the Lehigh Valley Physicians
organization. Board members
discussed the logic of these
organizations and how they would
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Two Management Appointments Announced
Elliot I. Sussman, M.D., President and
Chief Operating Officer, recently
announced the appointments of James
B. Burke as Vice President of Site
Operations for 17th & Chew, effective
June 1, and Louis L. Uebhaber to· the
position of Chief Operating Officer.
Mr. Liebhaber will assume his duties
on July 11.
In his new position, Mr. Burke will be
responsible for all day-to-day activities,
including the transition of all clinical
services at 17th & Chew. He will
direct the consolidation of acute care
inpatient pediatrics and
medical/ surgical services and help to
implement and operate the hospitalbased skilled nursing facility and
interim ambulatory surgery at the site.
He will report directly to the chief
operating officer.
Prior to joining Lehigh Valley
Hospital, Mr. Burke was director of
program and operations analysis for the
Hospital of the University of
Pennsylvania since 1986, where he
directed a variety of activities ranging
from management engineering projects
to programmatic business planning.
Mr. Burke began his career in 1981 as
a management engineer for Frankford
Hospital in Philadelphia, and in 1985
was named corporate management
engineer for Universal Health Systems,
Inc., in King of Prussia.
A 1979 graduate of the University of
Pennsylvania with a B.A. in
Economics, Mr. Burke also holds a
masters degree in business
administration from Drexel University.

He and his wife, Kathleen, recently
became· the parents of triplets, James,
Christopher, and Elizabeth.
With over 20 years of health care
management experience, Mr.
Liebhaber has strong skills in team
building, resource management,
physician relations, managed care, and
staff and management communications.
As the Chief Operating Officer, he will
manage daily hospital operations. He
will work closely with administrative
and management staffs, guide, direct,
and assure the efficient and effective
operation of hospital departments,
systems, programs, projects, and
patient care and support staffs.
Currently, Mr. Liebhaber is vice
president for operations at Beth Israel
Medical Center (BIMC) in New Yorlr
City with responsibility for the daily
operations of the facility. He began at
BIMC in 1983 as assistant director for
operations. The system includes Beth
Israel Medical Center, a 949-bed, full
service, teaching hospital affiliated
with Mt. Sinai School of Medicine;
Beth Israel Hospital-North, a 229-bed
acute care hospital; Beth Israel, a 245bed long term care facility in
Westchester County; the Phillips Beth
Israel School of Nursing; and New
York Health Care, a comprehensive,
ambulatory care facility.
Some of Mr. Liebhaber's professional
accomplishments during his tenure at
BIMC include implementation of a
clinical lab commercial joint venture;
establishment of a designated AIDS
Continued on Page 7
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center; d~velopment and
implementation of extensive home
infusion therapy program; expansion of
pre-admission testing; implementation
of a program to reduce obstetrical
length of stay; development of a
concurrent mortality review and quality
assurance program; and participation in
Beth Israel's $54 million modernization
and expansion program.

Mr. Liebhaber earned his B.A. at
Brandeis University in 1972. He
received his M.B.A. with a
concentration in health care
management from Boston University in
1975. He is married and has two
children, aged eight and ten. His wife,
Barbara, is an accomplished musician ·
and teaches part-time.

Saturday Transfers to Good Shepherd Rehab Hospital
Good Shepherd Rehabilitation Hospital
will now accept transfers on Saturdays.

In April, Good Shepherd Rehabilitation
Hospital began accepting Saturday
transfers of stable orthopedic patients.
They have since expanded to now
accept strokes and amputees and will
continue to evaluate and expand this
service as the need expands.

•

Transfer will occur between
8:30 and 9:30 a.m. to allow
patients to receive therapy at
Good Shepherd Rehabilitation
Hospital.

If you have any questions or need more
information, please contact Susan L.
Lawrence, Director, Integrated Quality
Assurance/Resource Utilization
Management, at 402-2414.

Key points to remember if you wish to
transfer your patient on a Saturday
include:
•
•

•

•

Patient must be medically
stable.
All transfer orders must be
complete and on the chart
Friday.
Decision to transfer must be
made Friday in order to get
chart copied and arrange
transportation.
Good Shepherd Rehabilitation
Hospital has a limit of three
patients they will accept on
Saturday.
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Welcome, New Housestaff
Please join the Office of Education in
welcoming the 44 new housestaff
beginning their resident education at
Lehigh Valley Hospital the week of
June 24. They are listed below, along
with their dental, medical or
osteopathic school.

Colon and Rectal Surgery
• JeffreyS. Aronoff, M.D., University of
Medicine and Dentistry of New Jersey
• Paul A. Lucha, D.O., University of
Medicine and Dentistry of New Jersey

Dentistry
• Karen M. Bond, D.D.S., University of
Maryland
• John W. Capparell, D.M.D., Temple
University School of Dentistry

General Surgery
• William J. Edmiston, Jr., M.D., Ross
University School of Medicine
• Edward J. Frick, Jr., M.D., Temple
University
• EllenA. Janetzke, M.D., Wayne State
University
• Paula A. Lundgren, M.D~, Jefferson
Medical College
• Robert W. Watson ll, M.D., University of
Nevada Medical School
• Stuart J. White, M.D., University of
Medicine and Dentistry of New Jersey

lnte17UJI Medicine
• Sanjay Arora, M.D., HalmMIIDD University
• Anjam N. Bhatti, M.D., Mebany Medical
School
• Armando A. DeFeria, M.D., Ross
University
• Jeaninne M. Einfalt, D.O., Philadelphia
College of Osteopathic Medicine
• Jeffrey D. Gould, M.D., Habnemann
University

• Dawn M. Kemledy, D.O., Philadelphia
Collcp of Osteopathic Medicine
• Andras Koller, M.D., Ushgorod State
University
• Anthony V. Matejicka U, D.O., Philadelphia
College of Osteopathic Medicine
• ~id Mushtaq, M.D., King Edward
Medical College
• Sethuraman Muthiah, M.D., MRCP-Ireland
• Malcolm C. Townsley, M.D., Georgetown
University School of Medicine

Obstetrics and Gynecology
• Deborah A. Lebrich, M.D., Medical
College of Pennsylvania
• Bani A. Sarma, M.D., Temple University
• Rose Mary Sobel, M.D., Jefferson Medical
College
• Aline-Marie Tomlinson-Jones, M.D.,
University of Medicine and Dentistry of New
Jersey

Osteopllthic Emergency Medicine
• Tncy C. Barber, D.O., University of
Health Science, Mi880uri
.• Gary M. Bonfante, D.O., Philadelphia
College of Osteopathic Medicine
• Heath A. Jolliff, D.O., Ohio University
College of Osteopathic Medicine
• Kevin J. O'Gara, D.O., University of
Health Science, Mi880uri

Pathology
• Eugene Alexandrin, M.D., Kbarkov Medical
Institute

Plastic Surgery
• Katheryn M. Warren, M.D., University of
CoDDeCticut Health Center

Continued on Page 9
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Radiology
• Rick G. Clark, D.O., Philadelphia College
of Osteopathic Medicine
• SUZ81U1e C. Moffit, D.O., Michipn S~
University
• John J. Zoshak:, D.O., Philadelphia Colleae
of Osteopathic Medicine

Trauma ISurgical Critical Care
• Richard A. Damian, M.D., State University
of New York Health Science Center at
Syracuse

• Ou:istine E. Hinke, M.D., New York
Medical Collep
• Robert C. Moraan, M.D., HabMID!IDD
University
• Yong T. Oh, M.D., HahnoiDIIIIl Uaiversity
• Todd A. Phillips, M.D., Loma Linda
Uaiversity School of Medicine
• Elmer G. Pinzon, M.D., Hahnemann
Uaiversity
• John L. Poag ll, M.D., Medical College of
Georgia
• Charles M. Terry, M.D., HahnemaDn
University
.• Joseph F. Waldner, M.D., Habnemann
University

TransitioiUll Year
• Craig K. Depoe, M.D., Hahnemann
University

Lehigh Valley Hospital to Participate in Clinical Trial
Lehigh Valley Hospital has been
accepted as one of only 200 sites to
participate in the Antihypertensive and
Lipid-Lowering Therapy to Prevent
Heart Attack Trial (ALLHAT)
sponsored by the National Heart,
Lung, and Blood Institute. Nelson P.
Kopyt, D.O., nephrologist, will serve
as the physician investigator for the
hospital.

For more information, contact Dr.
Kopyt at 432-8488 or Mary Ann
Gergits, Research Nurse Coordinator,
Department of Medicine, at 402-0544.

At least 150 high-risk hypertensive
patients will be recruited to participate
in the trial. Candidates will include
men and women over age 60 with high
blood pressure and at least one other
risk factor of heart disease, e.g., type
11 diabetes, hx. of CABG, HDL
< 35mgldl, and documented ASCVD
or carotid disease not requiring
surgery. Enrollment will begin this
fall.
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Coding
The following continues our list of
common conditions which are not
consistently documented in the medical
record.
DIAGNOSES

Accurate documentation enables
accurate data collection and optimal
reimbursement.
Thank you for your cooperation in this
matter.

Atrial Fibrillation
Ventricular Tachycardia
Atrial Flutter
Chronic Angina
Congestive Heart Failure (CHF)
Compensated
Hypotension

One Office Manager's System of Checks and
Balances by Eva Ritter Levitt
Every office needs a system of checks
and balances for accuracy and office
security. There are six key areas to
consider: patient registration at the
front desk, patient discharge with
check out receptionist, checks or cash
that arrive by mail or "walk ins,"
hospital billing, payroll, and payment
of invoices.
• When a patient registers for an
appointment, he/she should have a
router (superbill) attached to the chart.
The router should have a number, the
date, and the patient's name. The
receptionist needs to check this
· information and list the previous
balance on the router.
• At the conclusion of the visit, the
doctor must mark the router with the
diagnosis, and check the appropriate

CPT code(s) to be charged. The
patient proceeds to the check out
receptionist who enters the charges into
the computer and collects payment if
the patient is a self-pay or if there is a
co-pay or deductible and refers the
other charges to insurance. The check
out receptionist places the payment in a
bank envelope and completes the
bottom of the router with the amount
collected and what was billed to the
insurance company. The patient is
given a copy of the superbill or a
computer equivalent. At the end of the
day' the check out person will count up
all the routers and fill out a cover sheet
where she marks the number of
patients seen that day and the number
of routers entered. The two numbers
should match. She runs a total of the
Continued on Page 1 1
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checks and cash received. This packet
is then given to a person in the billing
department who must verify that a
charge was generated for each patient
listed in the appointment book. If a
patient's visit was cancelled, the router
should appear in the packet with
"cancelled" written on it. Thus, if 20
patients are on the daily list, there
must be 20 routers at the end of the
day.
• Hospital charges should be entered
by the billing section. The doctors
should provide the hospital charges to
the billing section as soon as each case
is completed, thus enabling the billing
staff to process the bills in a timely
manner to the proper sources. The
billing section should maintain a record
of all hospital consults listed and check
the charges against this list to verify
that every inpatient gets billed.
• Checks received in the daily mail
must be opened by a person different
from the one who posts the payments
in the computer or on the charge cards.
Ideally, this individual should make a
list of the patient name and the amount
received. The office manager should
review the incoming checks to verify
which accounts are being paid and
which accounts need to be reviewed.
The checks are then given to a member
of the billing staff, preferably an
individual other than the one who
enters the hospital charges.

a copy of the deposit slip as supporting
documentation in the event that
questions arise regarding the checks.
This individual must confirm that each
check received by mail has been
posted. Verification can be made
against the list that was prepared by the
receptionist who opened the checks.
The totalled checks and cash must
equal the total payments for the day
according to the computer or the peg
board sheet. Ideally, the deposit
should be reviewed and made by one
()f the doctors on a daily basis.
• A part-time bookkeeper pays all
invoices with checks which are signed
by one of the doctors or the office.
manager. Payroll is done by a
computerized payroll service which
provides a print-out of cumulative total
of salaries and deductions for each pay
period.

In summary, for office accuracy and
security, it is important to have several
distinct members of the staff involved
in the handling of the monies generated
by a practice and in the payment of
bills. A system of checks and balances
with office manager and physician
oversight shoUld prevent problems
from arising.

• The daily deposit should be
processed by someone in the billing
section. This individual must collate
the payments from the discharge
receptionist and the daily mail. All
checks should be copied and stapled to
Page 11

PHAMIS LastWord Training Schedule for Physicians
Following is a schedule of classes to be
held by Information Services regarding
PHAMIS LastWord training for
physicians, residents, and allied health
personnel.
Tuesday, June 21 - 5 to 7 p.m.
Thursday, July 7- 6 to 8 a.m.
Tuesday, July 12- 1 to 3 p.m.
Wednesday, July 20- 5 to 7 p.m.

Classes will be held on the first floor
of the School of Nursing at 17th &.
Chew.
To register for a class, or if you have
any questions, please contact Diann
~rey in Information Services at
402-1404.

Congratulations!
Wayne E. Dubov, M.D., physiatrist,
successfully passed the required
examination and has now beCome a
Diplomate of the American Board of
Electrodiagnostic Medicine.
Peter A. Keblish, M.D., chief,
Division of Orthopedic Surgery, has
accepted the position of Review Editor
for the Joui'IUll of OrthoptUdic
RheumlltOlogy. Manuscripts will be
sent to Dr. Keblish for his expert
orthopedic evaluation and comments.
David Prager, M.D., hematologist/
oncologist, and Medical Director, John
and Dorothy Morgan Cancer Center,
was recently elected to the Board of
Directors of the American Society of
Clinical Oncology. In addition, he was
also appointed to the Executive
Committee of the National Surgical
Adjuvant Breast and Bowel Project.

society's 93rd annual convention, May
8-13. During this conference, he
presented the current status of practice
parameters for colon and rectal surgery
at the State of the Society symposium.
Dr. Rosen also served on an expert
panel for clinical case presentations.
John J. Stasik, Jr., M.D., chief,
Division of Colon/Rectal Surgery, has
_been appointed to the Quality
Improvement Committee of the
Community Choice health care plan.
He was nominated for this appointment
by Lehigh County Medical Society to
represent specialty services. He is the
only surgical specialist on this
committee.

Lester Rosen, M.D., colon and rectal
surgeon, was elected to the Executive
Council of the American Society of
Colon and Rectal Surgery during the
Page 12

Publications, Papers and Presentations
Thomas B. Dickson, M.D., and
Thomas D. Meade, M.D., orthopedic
surgeons, were presenters at the Sports
Advisory Board Conference for Senior
High Athletes and their Coaches at
Lehigh University on April 27. The
program was sponsored by the Alcohol
and Drug Dependence Center - Lehigh
Valley. Dr. Dickson's presentation
was Nutrition and Steroids; Dr.
Meade presented Sports Injury
Prevention.
Jane Dorval, M.D., chief, Division of
Physical Medicine and Rehabilitation,
was an invited speaker at Prevention
of Secondary Conditions Associated
with Spina Bifida and Cerebral·
Palsy, a symposium sponsored by the
Spina Bifida Association of America,
United Cerebral Palsy Associations,
Inc., Centers for Disease Control and
Prevention, and the National Institutes
for Health, held in Washington, DC,
on February 19.
Dr. Dorval also presented Promoting
Independence in Children with
Disabilities at the Seventh World
Congress of the International
Rehabilitation Association meeting held
in Washington, DC, in April.
Jason Green, M.D., Colon/Rectal
Surgery Resident from 1992-93,
presented Transanal Diskectomy for
Cure of Rectal Adenocarcinoma: Is
Clinical Judgment Accurate? at the
93rd annual convention of the
American Society of Colon and Rectal
Surgeons in Orlando, Fla. This paper
reviewed the outcome of 104 patients
with carcinoma of the rectum who
underwent transanal diskectomy with

attempt to cure. Robert D. Riether,
M.D., colon and rectal surgeon, is the
senior author of the paper which will
be submitted to Diseases of the Colon
and Rectum for publication.

Houshang G. Hamadani, M.D.,
psychiatrist, presented a paper at the
American Psychiatric Association
Annual Meeting in Philadelphia on
May 24. The title of the paper is
Actions and Reactions of the Host
Country, Part of the Compentent on
Opportunities in International
Psychiatric Exchanges.
Thomas D. Meade, M.D., orthopedic
surgeon, is spearheading a Shoulder
Improvement Day in cooperation with
the Allentown Sports Medicine and
Human Performance Center and
Affinity. This is a free public service
offering evaluations from orthopedic
surgeons, physical therapists, exercise
physiologists, strength trainers, and
sports specific coaches to any
individual interested in maximizing
their shoulder function at work and in
sports. The program will be held on
Saturday, June 18, from 9 a.m. to
noon, at the Allentown Sports
Medicine and Human Performance
Center in the lower level of 1243 S.
Cedar Crest Boulevard, Allentown.
David P. Steed, D.P.M., chief,
Section of Podiatry, and Scott J.
Upkin, D.P.M., podiatrist, coauthored A Human Cultured Dermal
Replacement for the Treatment of
Diabetic Foot Ulcers. This was
presented in April at the Seventh
Annual Symposium on Advanced
Wound Care in Miami Beach, Fla.
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Upcoming Seminars, Conferences and Meetings

Department of Pediatrics
Update on Epilepsy will be presented
by Martha A. Lusser, M.D., chief,
Division of Pediatric Neurology, on
Friday, June 24, beginning at noon in
the Auditorium of Lehigh Valley
Hospital, 17th & Chew.

• For Sale or Lease -- Springhouse
Professional Center, 1575 Pond Road. Ideal
for physician's office. Approximately 1,000
sq. ft.

PHYSICIAN

PRAC1tE
OPPORTlHI'IES

• For Sales or Lease -- Medical/Professional
three-story office building at 1730 Chew
Street, Allentown. Excellent condition with
recent renovations. Approximately 6,800
sq. ft. for single or multiple specialty
practice. Includes long-term parking lease
at Fairgrounds. Potential telephone and
dictations systems.
• For Sale -- Office building at Northeast
corner of 19th and Turner Streets in
Allentown. Upper level - 2,400 + sq. ft.,
large waiting room, two large consultation
rooms, five exam rooms, etc. Lower level2,300+ SQ; ft. Parking lot for 16 cars.
• For Lease -- Office to sublet on Monday,
Tuesday, Thursday, and Friday. 950 sq. ft.
Common waiting area. Lakeside
Professional Building, Quakertown.
• For Lease -- Large, newly remodeled,
completely furnished medical office space
available for subleasing/time share at Cedar
Crest Professional Park. Top of the line
telephone system. Transcription and
computer system with electronic billing
available
• For Lease -- Slots are currently available
for the Brown Bag suite at Kutztown
Professional Center. Ideal for satellite
location.

For more information, contact Beverly
Humphrey in the Department of
Pediatrics at 402-2410.

• For Lease - Several time slots are
available in the medical office building on
the campus of Gnaden Huetten Memorial
Hospital in Lehighton.
• For Lease -- Medical-professional office
space located on Route 222 in Wescosville.
Two 1,000 sq. ft. offices available or
combine to form larger suite.
• For Lease-- Medical office space located
in Peachtree Office Plaza in Whitehall. Ont"
suite with 1,500 sq. ft. (unfinished allowance available), and one 1,000 sq. ft.
finished suite.
• For Lease -- Specialty practice time-share
space available in a comprehensive health
care facility. Riverside Professional Center,
4019 Wynnewood Drive, Laurys Station.
Half- or full-day slots immediately available.
• For Lease -- Professional office space
available in an established psychology and
psychotherapy practice at 45 N. 13th
Street, Allentown. Large, warm Victorian
building in a relaxed atmosphere. Secretary
and billing available and included in some
leases. Furnished or unfurnished full offices
and sublets available. Utilities included.
For more information or for assistance in
finding appropriate office space to meet
your needs, contact Joe Pilla, Physician
Relations Rep, at 402-9856.
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WHO'S NEW

Additional Privileges

The Who's New section of Medical
Stqff Progress Notes contains an
update of new appointments, address
changes, newly approved privileges,
etc. Please remember that each
department or unit is responsible for
updating its directory, rolodexes and
approved privilege rosters.
'

Peter J. Barbour, MD
Department of Medicine
Division of Neurosciences
(Lehigh Neurology)
Active
Treatment of Dystonia with Botulinum
Toxin

Medical Staff
Appointments
Nicholas C. Kyriazi, MD

Mario A. Candal, MD
Department of Obstetrics and
Gynecology
Division of Obstetrics/Gynecology
Section of Benign Gynecology
Courtesy
Obstetrical Privileges

Family Pediatricians, Inc.
(Dennis W. Kean, MD)

Allentown Medical Center
401 N. 17th Street, #109
Allentown, PA 18104-6804
(610) 435-6352
Department of Pediatrics
Division of General Pediatrics
Provisional Active

Richard J. Morse, MD
Lehigh Valley Pediatric Associates
(Oscar A. Morffi, MD)

Allentown Medical Center
401 N. 17th Street, #307
Allentown, PA 18104-5051
(610) 434-2162
Department of Pediatrics
Division of General Pediatrics
Provisional Courtesy

Ralph E. Stolz, DO
(solo)
Doctors Clinic
555 Harrison Street
Emmaus, PA 18049-2339
(610) 967-3115
Department of Family Practice
Provisional Active

Robert J. Coni, DO
Department of Medicine
Division of Neurosciences
(Neurological Services)
Active
Treatment of Dystonia with Botulinum
Toxin

John D. Farrell, MD
Department of Family Practice
(Parkland Family Health Center)
Active
Emergency Medicine Privileges

Arthur E. Fetzer, MD
Department of Surgery
Division of Urology
Active
Collagen Implantation Privileges

HughS. Gallagher, MD
Department of Medicine
Division of Cardiology
(Cardiovascular Associates)
Active
Stent Placement Privileges

Page 15

Linda L. Lapos, MD
Department of Surgery
Division of Colon and Rectal Surgery
(solo)
Active
Transrectal IDtrasound

Richard M. Liebennan, MD
Department of Surgery
Division of Urology
(solo)
Active
Collagen Implan~tion Privileges

Mario A. Candal, MD
Department of Obstetrics and
Gynecology
Division of Obstetrics/Gynecology
Section of Benign Gynecology
(Hospital)
From Courtesy to Provisional Active

James T. Dorsey, MD
Department of Obstetrics and
Gynecology
Division of Gynecology
Section of Benign Gynecology
From Active to Honorary

James L. McCuUoup, MD
Department of Surgery
Division of Vascular Surgery
(Peripheral Vascular Surgeons)
Active
Placement of Transluminal Peripheral
Arterial Stents

Bruce R. Ganey, DPM
Department of Surgery
Division of Orthopedic Surgery
Section of Podiatry
(solo)
From Courtesy to Provisional Active

Craig R. Reckard, MD
Department of Surgery
Division of General Surgery
Section of Transplantation Surgery
(solo)
Active
Proctosigmoidoscopy Privileges

$baron M. GausJ.in&, MD

Change of Status
Judith N. Barrett, MD
Department of Family Practice
(solo)
From Courtesy to Provisional Active

J. Grea Brady, DO
Department of Medicine
Division of Dermatology
(Stephen M. Purcell, DO)

From Provisional Consulting to
Provisional Active

Department of Pediatrics
Division of General Pediatrics
(Children•a HealthCare)

From Active to Courtesy

Dieter W. Leipert, DDS
Department of Surgery
Division of Oral and Maxillofacial
Surgery
(solo)
From Courtesy to Provisional Active
Nancy A. Mao, MD
Department of Medicine
Division of General Internal Medicine
(Sam Bub, MD)

From Courtesy to Provisional Active

Russell B. Puschak, MD
Department of Pediatrics
Division of General Pediatrics
(solo)
From Active to Emeritus Active
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Thomas Renaldo, DO
Department of Family Practice

Division

(MacArthur Medical Center)

Richard C. Boorse, MD
George S. Boyer, MD
William W. Frailey, MD
Milton J. Friedberg, MD
Mark A. Gittleman,· MD
George W. Hartzell, MD
Ismail Nabati, MD
;peter F. Rovito, MD
Barry H. Slaven, MD

From Courtesy to Provisional Active
David M. Stein, DO
Department of Medicine
Division of General Internal Medicine
(solo)
From Courtesy to Provisional Active

Larry W. Todd, DO
Department of Family Practice

General Suraery

Division of General Suqery/Trauma

(MacArthur Medical Center)

From Courtesy to Provisional Active
Gregory Tomcho, DO
Department of Family Practice
(MacArthur Medical Center)

From Courtesy to Provisional Active
Andrea Waxman, :MD
Department of Obstetrics and
Gynecology
Division of Obstetrics/Gynecology
Section of Benign Gynecology
(Mary T. Zygmunt, DO)

From Courtesy to Provisional Active
Mary T. Zyamunt, DO
Department of Obstetrics and
Gynecology
Division of Obstetrics/Gynecology
Section of Benign Gynecology
(with Andrea Waxman, MD)

From Courtesy to Provisional Active

Department of Surgery
Division Reassignments
(Reassignment of membership in the
Department of Surgery - Division of
General Surgery as a result of a
revision to the Medical Staff Bylaws in
which the section of Surgical Oncology
has been deleted.)

Charles J. Scagliotti, MD
Kamalesh T. Shah, MD
Gerald P. Sherwin, MD
Division of General Suraery, Section
of Critical Care

Nora A. Suggs, MD
Douglas R. Trostle, MD
Division of General Suqery/Trauma,
Section of Critical Care

Kevin E. Glancy, MD

·Department of Obstetrics and
Gynecology Division/Section
Reassignments
(Reassignment of membership in the
Department of Obstetrics and
Gynecology as a result of a revision to
the Medical Staff Bylaws in which
various Division and Section titles have
been renamed.)
Division of Gynecology, Section of
Gynecologic Oncology
Gazi Abdulhay, MD
Sergio Perticucci, MD ·

}
Page 17

Division of Gynecology, Section of
Pelvic Reconstructive Surgery
Vincent R. Lucente, MD
Division of Gynecology, Section of
Reproductive Endocrinology &
Infertility
Bruce I. Rose, MD
Sta.cie I. Weil, MD
Division of Obstetrics, Section of
Maternal-Fetal Medicine
Robert 0. Atlas, MD
James Balducci, MD
Anthony Johnson, DO

Sheldon H. Linn, MD
Howard M. Listwa, DO
Gene W. Miller, DO
Joseph A. Miller, MD
Ernest Y. Normington ll, MD
MichaelS. Patriarco, DO
Gregory J. Radio, MD
Charles W. Reninger, MD
Bruce M. Rodenberger, MD
Daniel M. Schwartzman, MD
GeorgeS. Smith, MD
Stanley Snyder, MD
M. Bruce Viechnicki, MD
Michael Vigilante, MD
Andrea Waxman, MD
Concepcion T. Yen, MD
Mary T. Zygmunt, DO

Address Changes
Division of Primary Obstetrics and
Gynecology
Lisa Baker-Vaughn, MD
Gail E. Burgey, MD
Mario A. Candal, MD
Sungji Chai, MD
Robert V. Cummings, MD
James T. Dorsey, MD
Henry H. Fetterman, MD
Beth A. Folio, MD
Lyster M. Gearhart, MD
Edward E. Geosits, DO
Larry R. Glazerman, MD
T. A. Gopal, MD
Joseph N. Greybush, MD
Zirka M. Halibey, MD
Thomas A. Hutchinson, MD
EarlS. Jefferis, Jr., MD
Ellen M. Joyce, MD
Bruce M. Kaufmann, MD
Stephen K. Klasko, MD
Donald B. Kopenhaver, MD
John B. Kucharczuk, MD
Carl A. Lam, MD
Chong S. Lee, MD
David Lezinsky, DO

Elizabeth Knapper, MD
2895 Hamilton Blvd.
Allentown, PA 18104
(Effective 7/1/94)
Dominic P. IAI, DDS
6505 Route 309
New Tripoli, PA 18066
(610) 298-8805
Richard J. Strisofsky, DMD
127 Bridge Street
Catasauqua, PA 18032
(Effective 6/27/94)

Baqamin Weinberaer, DMD
Springhouse Oral Surgery
1575 Pond Road
Suite 204
Allentown, PA 18104-2254
(610) 366-9616
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Practice Name Change
The practice of Stephen M. Purcell,
DO, and I. Greg Brady, DO, will now
be known as Advanced Dermatology
and Skin Cancer Center.

Allied Health
Professionals
Resignation
Kathleen A. Leh, RN

Practice Change

Physician Extender
Professional - RN

Marc W. Levin, MD, has joined

(Dr. Subzposh)

Advanced Dermatology and Skin
Cancer Center (Stephen M. Purcell,
DO, and I. Greg Brady, DO)

Unit Director Appointment
Michael Pasquale, MD
Medical Director
Transitional Trauma Unit

Death
Guy L. Kratzer, MD
Department of Surgery
Division of Colon and Rectal Surgery

3/18/94
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Physician Well-Being Group
Stress Check
John C. Turoczi, Ed.D., FacDitator
Take a few minutes to check your stress and bum-out level.

Physician Stress Inventory (May and Revicld)
(Circle the appropriate number on the 1-41Cale aa it applies to you.)

Does not apply

tome
1

2

Does apply
tome
4

3

1. I am no longer the "contributor" I used to be . . . . . • . • . . • . . . . • . . . . . . . . . . . . . . . . . . 1 2 3 4
2. My initial expectations of my job 111e not being realized
.•..•.••..••.••.•..•.•.••• 1 2 3 4
3. My productivity has decreased .. ~ . . . . . . . . • . . . • . • • . . . . . • • • . . . . • . . . . . . . . . . . 1 2 3 4

4. I am less content with myself • . . • . . . . . . . . . . . • . . • . . • . • . . . . . • . . . . . . . . . • . . . .
5. I often find myself feeling resentful, disenchanted, bored, or disco1111l8ed • . . • . • • • • . . . • • . . .
6. Colleagues at work do not contribute their fair sbare • • • • • • • • • • • • • • • • • • • • • • • . • • • • •
7. Work interferes with family life . . . . . . . . . . . • . . . . . . . . . . • . . . . . . . . . . . . . . • . . . .
8. My professional growth and skills 111e stagnating • . . . . . . . . . . . . . . • . • . . . • . . . . . . . . . .
9. My preoccupation with work IDikes it bard to disengage from the job at home . . . . . . . . . . . . .
10. I am more edgy than I used to be . . . . . . . . . . • • . • . . • . • • • • . . • . . . . . . . . . . . . . . . .
11. It seems like I just cannot get the recognition I feel that I deserve • . • . . . . . . . . . . . . . . . . . .
12. I feel guilty when I caunot completely understand my patieots or clieots . • . • . . . . . . . . . . . . .
13. It seems like I have very little power to control the things that happen' to me . • . • . . . . . . . . . .
14. I am working harder but getting less done • . . . . • • . . . • • . • . . • . • . . . . . . . . . . . . . . , . .
15. I often feel that others are out to •screw• me • . • • • • • • • • . . . • • • • • . • . . • • . . . . . . . . . .
16. Things of minor relevance now make me angry and frustrated •••••••••.••••..••.••.•
17. I often arrive late for work • . . . . . . . . . . . . • • • . . • • • • . • • . • . . . . . . . . . . . . . . . . . .
18. I occasionally hide in my office in order to shut out others . . . . . . . . . . . . . . . . . . . . . . . . .
19. Arguments at home with spouse, children or others close to me have increaaed recently . . . . . . .
20. I daydream more at work than I used to • • . • . . • . • • . • • . . . . . • . . . . . . . . . . . . . . . . . .
21. My responsibilities 111e much different than I had anticipated •• ·. • • . . . • • . . . . . . . . . . . . . .

1 2 3-4
12 34
12 34
12 34
12 34
12 34
12 34
12 34
12 34
12 34
12 34
12 34
1234
12 3 4
12 34
12 34
12 34
12 34

22. Support for my contribution at work has been consistently lacking . . . . . • . . . . . . . . . . . . . . . 1 2 3 4

TOTAL SCORE
Interpretation: Total the number of points.
Less than 42
- Below average stress rating
42-60
- Average stress rating
Greater than 60 - Above average stress rating

Participation in the Weii-Beina Group:
Less than 42
- Share with your colleagues how you do it!
42-60
- Share your coping strategies and do aome preventative work.
Greater than 60 - Perhaps you need some support, new coping and stress redUcers.
Research indicates that one of the best stress relievers for physicians is a peer support group. The next meeting
of the Physician Well-Being Group open to new members is August 8. For more information, contact John C.
Turoczi, Ed. D., group facilitator, at 481-9161.
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Cedar Crest & I-7H
Post ( )ffice Box 6H9
Allentown, Pennsylvania I HI 05-15 56

HEALTH NE1WORK
lABORATORIES
June, 1994

A Service of ILHU?H VAJ..LE'V
HtJSPfi:U.

Dr. Doctor:
The Clinical Laboratory has responded to an interest voiced by some of our
Medical Staff for a service enhancement related to result reporting i.e.,
faxed reporting. We have been working closely with Hospital Information
Services to complete this task and are pleased to announce we have been
successful in passing clinical lab results from the Lab computer system
(Sunquest) to the Tandem platform and then from there to fax machines located
in physician offices.
Pathology and Cytology reports are not available via
this method however they can be faxed utilizing different mechanisms.
We are now at the juncture in this project where we need to assess your
interest and willingness in using Jthese electronic reporting capabilities.
Please understand that the report you receive via fax would be your only
copy. To assist you in this decision ~recess we have created a list of
benefits and considerations (see back) .
Please .indicate whether you would use this service or not by:
•
checking a box or boxes below
•
signing and returning this letter to Sharon L. Boley,
Lab Administration ~ 17 site by July 15, 1994
The results of this survey will help us determine the future of this project,
i.e. move forward to implementation, table for future consideration, or drop
the project.
Thank you.
Sharon L. Boley
Manager, Peripheral & Ancillary Sites
Lab Admin 17; Ext. 2552

D

D
D
D

Jane E. Erdman
Manager, Lab Information
Services CC; Ext. 8169

Yes I would use the clinical lab faxing service and I
understand it is the only copy of the report I would receive.
Yes I would use the pathology faxing service and I understand
it is the only copy of the report I would receive.
Yes I would use the cytology faxing service and I understand
it is the only copy of the report I would receive.
No I am not interested.

Signature
c:\wp51\sharon\resrpt.ltr

Date
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CONSIDERATIONS

•

•

the faxed report
is your only
copy

•

photocopying of
faxed report lS
necessary if
plain copy fax
not available ln
office

faster turnaround-time· for
results
reporting--faxed results
available daily
prior to 0900

0

I

I

•

no misdirected
mail

•

inpact on
office fax
machine and
acessibility
for other
functions
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HEALTH NETWORK

LABoRAToRIEs
A Service of lEHigtiVAILEY
HOSPml..

Thyroid Definitions
A number of questions have been
asked as to what is the best thyroid test
or combination of tests for screening
and/or diagnosis of thyroid disease.
Before answering these questions in the
next newsletter we have described each
test with a discussion if appropriate, of
the methodology. A * precedes each
test where a change has occurred that
you may particularly want to review.
T4 (Total Thyroxine.) is the standard
screening test for thyroid function
which helps to screen for any type of
hypothyroidism or hyperthyroidism. It
is elevated in pregnancy and estrogen
therapy due to an increase in TBG
(thyroid binding globulin). It is
lowered in states of protein depletion
and with Dilantin or Testosterone
therapy. Assessment of TBG in
combination with T4 yields a calculated
T7 or Free Thyroxine Index which will
be "normal" in the presence of nonthyroidal conditions.
*TBI (Thyroid Bindin& Index> is the
T3RU (uptake) test. We prefer that
you order this test as TBI and not
T3RU, as T3RU is often translated into
a T3 TIA (triiodothyronine). This test
is an indirect measurement of TBG and
its only use is for the assessment of the
effects of protein binding of T4 in

conjunction with the interpretation of
the total T4 measurement. The T7
calculation is the T4 result multiplied
by this TBI percentage which
compensates or corrects for variations
in TBG.

IBG (Thyroid Bindin& Globulin) can
be measured directly by RIA as the.
protein concentration in mg/dl.
*TSH (Thyroid Stimulatin& Hormone.)
is the single most important tool for
the diagnosis of thyroid disorders. We
offer the 3rd generation assay at a
sensitivity of 0.01 mUlL. It exhibits
no crossreactivity with the other
glycoprotein hormones and is not
affected by protein binding. We
employ a chemiluminescent
methodology which produces the high
degree of sensitivity of this test. The
3rd generation TSH test is used to
monitor T4 replacement or suppressive
therapy, to quantify TSH in the
subnormal range and to distinguish
hospitalized patients with NTI (nonthyroid illness) from those with
hyperthyroidism. It also can be
utilized as a sensitive screening test for
primary thyroid disorder.
*Ef4 (Free T4) is the determination of
the quantity of thyroxine in the blood
not bound to protein. Only 0.1% of
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the T4 is the free metabolically active
hormone available to tissues with the
rest bound to TGB, albumin and
prealbumin. Actually the FT4 test
could be a direct replacement for the
TI calculation because it is unaffected
by variations in serum T4 binding
proteins. Until now, the FT4 test has
been employed as a special
confrrmation test because the direct
equilibrium dialysis methodology was a
2 day, labor intensive, costly test not
suitable to automation. We are
presently using a one-step, automated
method which has been optimized to
eliminate T4 binding to endogenous
protein while leaving undisturbed the
original equilibrium between the free
and TBG bound T4. This FT4 test is
used to distinguish euthyroi4
hyperthyroximemia from
hyperthyroidism or euthyroid
hypothyroxinemia from hypothyroidism
and to monitor thyroid function and
replacement therapy in the setting of
hypothalamic pituitary disease.
T3 (Total triiodothyronine) is derived
predominantly from the
monodeiodination of thyroxine in
peripheral tissues (80%). It is present
in circulation at concentrations of only
1% of the T4 level but is 10 times
more active then T4 in binding to cell
receptors. T3 also called T-3 RIA is a
special test which helps in the
diagnosis of thyroid disorders causing
thyrotoxicosis.
FT3 (Free Triiodothyronine) is the
determination of the T3 hormone that
is extensively not bound to circulating
protein. Only the free hormone is
available to actively bind to receptor
sites. This test is quite expensive and
time consuming and so infrequently
required to make a diagnosis of thyroid

dysfunction that we have made it nonorderable except by special
consultation.
RT3 (Reverse triiodothyronine> is
derived from the removal of an iodine
molecule from T4 by the peripheral
tissues. Whereas T3 is 3, 5 ,3'
Triiodothyronine, the RT3 is 3, 3', 5'
Triiodothyronine which is
metabolically inactive. In nonthyroidal illnesses the conversion of T4
to T3 may be inhibited with a resulting
increase in inactive RT3. This test can ·
help in the diagnosis of a low T3
syndrome associated with non-thyroidal
illness.
Autoimmune-Thyroid disease is
associated with a wide variety of
heterogeneous thyroid-related
antibodies. These include
antimicrosomal antibodies, antithyroid
peroxidase antibody and a variety of
anti TSH receptor antibodies that maJ
be stimulating or inhibitory. In this
last category TSI (Thyroid Stimulating
Immunoglobulin) is elevated in Graves
disease. In general th~ antibody tests
are used for the diagnosis of the
different type of autoimmune thyroid

diseases.

Larry N. Merkle, M.D.
Endocrinology/Metabolism

Gerald E. Clement, Ph.D.
Clinical Laboratories
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Issues In Medical Ethics
Spring 1994

Editorial:

T

hanks to those who sent their comments in about Issues 1 and 2. They were
gratefully received and will be used in future issues. In this Issues number 3, a
panel of authors review the treannent ofJehovah's 'Witnesses in the hospital. It
is anecdotally interesting that the trend of medical practice away from widespread use of
transfusions has swept us nearer to the 'Wimesses, albeit for very different reasons. Some
of the information gathered from the treannent of patients with this religious belief may
in fact help treat others when transfusions are not an option for care, or under circumstances where transfusions become scarce... In this issue also, a review of What an Ethics
Consultion is. The committee has found there is still some confusion over when, and
why and how one proceeds with such a consultation...Finally, in this corner: the first in a
series ofK.rank commentaries. We hope this continuing series will provide an outlet for
those poor souls who have difficulty with the mainstream trends of medicine, prefering,
for example, to call a doctor a doctor and a nurse a nurse, and not a preferred provider...
Look for upcoming topics in the "Issues": ETillCS OF TRANSPLANTATION;
ETIDCS OF PAIN CONTROL; ETIDCS OF 'WITHDRAWING AND WITHHOLDING CARE.
-ARae-Grant

What Is An Ethics Consult?

1

Ethics of treating
Jehovah's witnesses
J.Fiesta, S.lammers,
B.Post,
A.Rae-Grant
What is an ethics
consult
S.Lammers
Krank's Korner
Anonymous

Members of the Ethics Committee have Include in the request the reasons why you
are asking for the consultation. (In other
observed that there is some confusion
words, please do not only say, "Consult
about the purpose of ethics consultations
and what actually happens during these
Ethics Committee.'') That request should
consults. To help out, they have prepared
be forwarded to the Critical Care Office
the following question and answer format. (ext. 8450). The chair of the Ethics Com1. "Who can call an ethics consult? A mittee should be paged if there is no timephysician can write a consultation request
ly response to the original request.
3. 'Who does the ethics consultain the chart or a nurse can request a consultation through their head nurse.
tions? After the chair of the Ethics ComPatients may also request an ethics consul- mittee determines that the request is in
fact for an ethics consultation, an interdistation through their physician, nurse or
the patient representative.
. ciplinary team is called. The team is head2. How do I call an ethics consult? If ed by a physician and three to six members
a physician, write a consultation request.
Continued on Page 2
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of the Ethics Committee join the team
leader to evaluate the case. All team members are volunteers.
4. "What does the ethics consultation
team do? This varies from case to case.
Generally, they examine the chart, speak
with nurses and physicians who have cared
for the patient. If possible, they speak with
the patient. Where required, they meet
with the patient's fumily and others who
may be empowered to speak fur the
patient.
Once they have gathered all the infOrmation they think necessary, the team
meets privately to discuss the case. After
discussion, the team usually makes recommendations. The team leader writes a
note to be placed temporarily in the
patients chart.
5. What if I disagree with the recommendation? This is only a recommendation. Physicians have disagreed
with ethics consultation recommendations
in the past in this hospital. We are happy
to report that this happens rarely, but it
does happen.
6. How long will I have to wait for a
request for a consultation to be filled?
The committee tries to fill all requests
within 48 hours. This is difficult if the
request comes in on Friday afternoon or
on New Year's Eve. The Critical Care

Office is closed after 5pm and is also
closed on weekends and holidays. If you
need information on the status of your
request, you can contact the Critical Cart.
Office or page the chair of the Ethics
Committee.
7. Why or when should I write for
an ethics consult? Should I always
request one when there is conflict or
when I am considering withholding or
withdrawing treatment? There are several questions here. Let us start with the
second one first. It is not always necessary
to ask fur an ethics consultation when considering withholding or withdrawing medical treatment. It is perfectly permissible
to withhold or withdraw medical treatment, assuming there are no ethical questions, without an ethics consultation. If ,
there is conflict, an ethics consultation
may be desirable, but again, this depends.
Often the conflict can be resolved by
physicians and nurses without the assistance of an ethics consultation team.
However, if there are ethical questions or
if there is some kind of ethical tension, thp
Ethics Committee is ready to help. If yo~
have any questions about whether a consultation is necessary, you can contact the
chair of the Ethics Committee and seek
her or his advice.

Topics in Bioethics:
Bioethics and Jehovah's
Witnesses:
A brief review
The treatment of patients who are Jehovah's Wimesses is complicated by ethical
issues related to transfusion. We will
briefly review the present state of treatment of]ehovah's Wimesses and discuss
some of the ethical issues surrounding

their care.
It is important to recognize that Jehovah's Wimesses do accept most medical
2

and surgical treatments. They fullow specific religious principles in regards to
blood transfusions which bring them into
conflict with medical advice. This is based
on their interpretation of certain biblical
passages:
"Only flesh with its soul-its blood- you
must not eat"
(Genesis 9:3-4)
Continued on Page~
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"pour its blood out and cover it with
dust"
(Leviticus 17:13-14)
"Abstain from ...what is strangled and
from blood"
(Acts 15:19-21)
(Dixon, 1981)
This refusal dates to a 1945 church
decision at a time when transfusions were
becoming medically established (Article,
1945). Witnesses view these statements as
forbidding transfusion of whole blood,
packed red blood cells, plasma, white
~lood cells, and platelets. Albumin,
un~une globulins, and blood factor preparanons are not specifically proscribed
(Mann, 1992). Each Witness must decide
individually if these latter types of treatments are acceptable to them. In addition
to the above, blood completely removed
from the body cannot be accepted, so that
autotransfusion of predonated blood is
forbidden (Green, 1990). Blood which
r~mai~s in continuity with the body, (i.e.
dtalysts or open-heart bypass), arid intraoperative salvage where the circulation of
blood extracorporeally is uninterrupted,
are all generally considered acceptable
(Dixon, 1981). If a Witness accepts transfusions, they are believed to be cut off
from eventual redemption. Some Witnesses believe that this is the case even if the
transfusion is accepted for the patient
and/or given to the patient against their
will.
A major precept ofbioethics is that
patients have a right to autonomy. Autonomy is de~ned i~ this setting as the right
to deternune whtch medical treatments are
~sed, inclll:ding life-saving or life-prolong~g therapt~s. Exceptions to this principle
mclude panents who demonstrate suicidal
tendencies, patients who are minors and
patients who are determined to be i~capable of such decision making. Other ethical co~ntervailing principles may also
come mto play, such as responsibility to
other family members.
The right to autonomy, extending as it

does to initiating, withdrawing and withholding medical treatments, allows Jehovah's Witnesses to specifically refuse transfusions. They do not forfeit rights to other
medical therapies aside from this. As with
any other refusal of treatment, they should
be made aware of the potential consequences of such refusal. Documentation of
such a refusal and discussion of the risks
should be placed in the medical record to
protect the physician and others attending
in the care of the patient.
Physicians should attempt to discuss the
issue of transfusion prior to surgery or situations where transfusions may arise to
c!ari,fy th~ patie~t's beliefs and the physi..:
ctan s dunes. Thts decision should be
clearly a voluntary one, and occasionally
such discussion should be held apart from
the presence of others to ensure this.
There may be situations where such discussions are impossible. In circumstances
where the patient's wishes are unknown
(i.e. unconscious patient known to be a
Jehovah's Witness) the physician may be
forced to err on the side of saving life. If at
all possible, consultation with the ethics
co~~ittee an~ with legal services may
asstst m resolvmg ethical dilemmas.
Though a particular religious belief may
be held.by others to be 'irrational', present
day ethtcal and legal arguments hold that
the patient is allowed to follow those
belie~ as long as they do not infringe upon
the nghts of others, constitute acts of
insanity, or contravene present law. The
principle of autonomy as described in the
~revious paragraphs includes the express1on of such a religious tenent.
In prescribing medical treatment the
risks and benefits must be weighed.'Transfusions, as a medical treattnent, are not
without risk. In a 1987 review, Walker
concluded that there was a 20% risk of
adverse effects, many of which were
. minor. Transfusion-associated hepatitis
and IllV are unusual risks, as are allergic
responses. There may be some risk of
adversely affecting cancer-free survival
Continued on Page 4
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after blood transfusions during cancersurgery (van Aken, 1989). A recent review
has emphasized the fact that transfusions
may be 'overrated', with a significant risk
of problems (Kitchens, 1993).
On the other hand, a review of surgery
in Jehovah's Witness patients suggested
there may not be an excess morbidity and
mortality, even in open heart surgery, renal
transplantation, and total hip replacement
(Kitchens, 1993). In one study (Nelson,
1986) 100 patients with standard total hip
replacement were compared with 100
Jehovah's Witnesses patients of the the
same age, sex and health status. Blood loss
was significantly less and operative time
shorter with the Jehovah's Witnesses, and
overall mortality and morbidity were the
same. The implication of these data is that
there may be more of a tradeoff in providing blood transfusion than previously considered (See also Dixon, 1981).
Over the years medical techniques have
been developed to cope with the problem
of avoiding blood transfusions in this
group of patients. A variety of alternate
procedures of varying risk and efficacy are
available and are the subject of specific
articles (See Mann et al, 1992). Generally
accepted strategies include providing crystalloids fur fluid replacement, giving
increased oxygen, minimizing blood loss,
using microchemical blood analysis to
reduce phlebotomy loss, using red cell
scavenging devices, using hypotensive
anesthesia, giving erythropoetin, and providing intravenous iron dextran. Experimental approaches with blood substitutes
are still being refined and currently are not
of proven value. Special expertise with
anesthesia and surgery in this group of
patients may assist in the outcome (Mann,
1992).
When the patient without decisionmaking capacity is a Jehovah's Witness, there is
only one acceptable basis for a religious
refusal of transfusion by the surrogate.
That would be in the case that the patient,
while he or she still had decision making
capacity, clearly and reliably expressed that

she/he was a Jehovah's Witness and would
not accept blood or blood products under
these circumstances. The physician shou]rl
seek ethical and legal advice on whether
the surrogate may decide to forgo treatment on religious grounds. There should
be evidence to support such a surrogate
refusal, as in the case of any patient without decision making capacity forgoing
treatment at a surrogate's request.
When a patient who is a Jehovah's Wit~
ness is pregnant, a refusal of blood or
blood products may jeopardize the care of
another who is incapable of decision making for themselves. In this situation careful
consideration by the institutional ethics
committee and/or legal services is important for the reasons described in other sections. Direct and tangible harm to the
fetus may occur as a result of forgoing
transfusion.
In the case of a minor there is limited
capacity to make medical decisions due to
age. The physician should seek ethical and
legal advice on whether the patient, parents, or another surrogate may decide to
furgo treatment on religious grounds.
Most courts have concluded that parents
cannot refuse blood and blood products
for a child on religious grounds, since this
may deprive the child of the opportunity
to decide as an adult whether to adhere to
the same religious principles. It may be
possible that in some special circumstances
a refusal may be ethically justified (For
example, a 15 year old patient with terminal cancer refusing further chemotherapy).
The physician has an obligation to preserve life where possible, and should err
on the side of such activity in the case of
minors.
In reviewing the literature on treatment
of]ehovah's Witnesses, a number of suggestions emerge. First, that}ehovah's Witnesses be accorded the same right of
refusal of specific medical therapies that
other patients are accorded. Second, that a
discussion of the types of allowed treatment take place, if possible, prior to
Continued on Page ..
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surgery or other procedures. Third, that
physicians experienced with the treatment
of these patient be involved in their care, if
possible. Fourth, that in circumstances of
an ethical dilemma, consultation with legal .
services and the institutional ethics committee be obtained for the couselling and
protection of the patient and physician.
-].Fiesta, S.Lammers,
R.Post, AD.Rae-Grant

REFERENCES:
Article, Immovable fur the right to worship.
Watchtower. 1945;66:195-196
Dixon,J.L., Smalley,M.G.Jehovahs Witnesses,
the surgicaVethical challenge. JAMA
1981;246:2471-2472

)

)

Green, D., Handley, E. Erythropoetin for anemia
in]ehovahs Witnesses. Ann.lnt.Med.
1990;113:720-721
Kitchens, C.S. Are transfusions overrated? Surgical
outcome ofJehovah's Witnesses. Am.J.Med.
1993;94:117-119

Mann, M.C., Votto, };, Kambe,J ., McNamee, M.J.
Management of the severely anemic patient who
refuses transfusion: lessons learned during the care
of a Jehovah's Witness. Ann.lnt.Med.
1992;117:1042-1048
Ross,].W., Bayley, C., Michel, V., Pugh, D. Handbook fur Hospital Ethics Committees, Chicago,
American Hospital Publishing, 1986, pgs.77-78
VanAken, W.G. Does perioperative blood transfusion promote tumor growth? Transfusion Med.Rev.
1989;3:243-252
Walker, RH. Transfusion risks. Am.J. Clin.Pathol.
1987;88:374-378

Krank's Korner
Why I Am Not
A Health Care Consumer?
There is a movement today to turn
health care into a business; it is said that in
this manner health care will become more
responsible. It may be that health care
needs to become more responsible about
the cost of care. However, in order to do
this, it is not necessary to use language that
is misleading.
Take the new name for patient! We are
now (remember, at some time, even you,
fellow health care worker, will join this
category) health care consumers. There
are automobile consumers, and· food consumers, and sporting goods consumers. I·
assume that by making patients health care
consumers the makers of language are trying to do two things. First, remind health
care workers that patients have choices
about where they go for health care and
second, remind patients that they should
be more responsible for how they spend
' their health care dollars. All of those

things seem to be reasonable, but that does
not make patients, especially in a high
technology hospital like this one, consumers.
For the essence of consumerism is
choice. I choose whether I want a car or
roller blades or Nintendo. I do not choose
to be admitted as a trauma patient and ifl
had a choice, I would just as soon pass the
open heart operation readily available
here. Most often, if I had a choice, I would
pass up being a patient for some other status, for example, being an Eagles fan. And
I do not want to be labeled so that anyone
is treating me as ifl had a choice about
being a patient.
The other side of this is that nurses and
physicians are not misnamed as well. I
have been reading a lot ofliterature which
speaks of them as "health care providers."
What is missing in that description is the
Continued on Page 6
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sense that what nurses and physicians
often "provide" is themselves, that they are
as much with patients as they are providing something for patients.
My worry here is that this misuse oflan-·
guage will never end. If we do not watch
out, pretty soon we will have a hierarchy
based upon a false understanding of medicine and nursing. In addition to health
care providers, we will have to have

Depamnents of Consumer Services. And
who knows· who these health care workers
used to be and what they are supposed to
be doing? "Why do we not name ourselve~ '
as we are, physicians, nurses, technicians,
therapists of different stripes, etc? At least
we would know who we are. And perhaps
our patients would as well.
KRANK'S KORNER is an irregular feature ofthe Ethics Newsktter.

Upcoming Events:
May 26th, Auditorium, LVH CC campus
"CPR and DNR; have we got the cart
before the horse?"

Look for announcements about an
upcoming symposium in the fall: "The
ethics of health care at the beginning and
end of life"

6
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P & T HIGHLIGHTS
The following action were taken at the May 9, 1994 Pharmacy and
Therapeutics Committee Meeting - James A. Giardina, Director of Pharmacy

FORMULARY ADDITION REQUESTS
Rocuronium (Zemuron, Organon) is a
new nondepolarizing neuromuscular
blocking agent, which has a quicker onset
of action with a comparable duration and
recovery to vecuronium (Norcuron).
Rocuronium' s potency is similar in young
and older patients, although both onset and
recovery are slower in the elderly. To
date, metabolites have not been detected in
the plasma or urine, and one third of the
dose can be recovered in the urine within
24 hours. In cats, a large portion is
excreted in bile; no data is available on
such elimination in humans, but hepatic
clearance could be significant. In patients
with renal failure, both total plasma
clearance and the volume of the central
compartment did not differ frOm patients
with normal renal function. However,
greater volume of dis~bution results in a
longer elimination half life in this
population. A bolus dose of 0.6mg/Kg
has been used to facilitate intubation.
Doses required to maintain paralysis via
continuous infusion in critical care patients
appear to be excessive and hence very

costly. This fact appears to be due to the
lack of an active metabolite. Adverse
rel!ctions to rocuronium have been minimal
and depending variable, on the study and
the defmition employed. Patients
receiving rocuronium have had either no
increase or a mean increase in heart rate
(Investigators did not rule <nit concomitant
drug therapy as a .cause). A transient
increase in heart rate was also seen in
children, aged 1 to 5. There were no
changes in blood pressure reported in the
several studies reviewed. Histamine
release has also not been reported in
premarketing data. Rocuronium has not
been studied in pregnant women or in
children less than 3 months old.
Monitoring similar to the other
neuromuscular blockers is recommended
utilizing a peripheral nerve stimulator. In
summary, rocuronium is an intermediate
acting neuromuscular blocker with rapid
onset of action. The committee approved a
three month trial of this agent in
Anesthesia controlled areas to coincide
with a review of this entire class of agents.
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Aprotinin (Trasylol, Miles) is a bovine
derived polypeptide that inhibits protease.
It is indicated for prophylactic use to
reduce perioperative blood loss and the
need for blood transfusion in select
cardiopulmonary bypass surgical patients.
Aprotinin has antifibrinolytic, hemostatic
stabilizing and weak anticoagulant effects.
The specific mechanism of action by which
it reduces perioperative bleeding is
unknown, however it appears to be due to
protection of circulating platelets.
Aprotinin is rapidly distributed into the
extravascular space following IV
administration. It has a plasma half life of
50 minutes, and a terminal elimination half
life of 10 hours. Aprotinin is sequestered
by the kidneys, following glomerular
filtration. It is stored in the
phagolysosomes of the proximal tubules
and has a half life within the kidney of
almost 24 hours. It is slowly degraded by
lysosomal enzymes.

Aprotinin has not been studied in
pregnancy or pediatrics, therefore the
manufacturer makes no recommendation
on use in these patients. Because it is a
bovine protein, Aprotinin has the potential
to cause allergic reactions. It should be
first given as a test dose (lml). Patients
who have previously received it should

also receive a HI-histamine antagonist
shortly before the loading dose. In a
pooled analysis of several studies, a trend
toward an increased incidence of MI as
well as increased incidence of saphenous
vein graft closure was seen. A significant
increase in renal dysfunction was seen in
treated vs placebo patients. Most cases
were not severe and were reversible. In
some studies, Aprotinin was safely given
to renal failure patients. Abnormal liver
function tests have also been reported
significantly more often in treated patients.
Aprotinin has been found to prolong the
ACT and the APTT. However, because
aprotinin possesses both anticoagulant and
antifibrinolytic effects, routine heparin
dosage adjustment is not recommended.
The manufacturer recommends use of
standard heparin loading doses and
redosing based on either a fixed dose
regimen (weight dosing & duration of
procedure) or based on heparin levels
based on a method unaffec~ by aprotinin
(protamine titration). Aprotinin is given as
a test dose, then a loading dose followed
by a pump priming dose and a continuous
infusion dose. It should be infused
through its own line. Aprotinin was added
for a three month therapeutic evaluation in
cardiothoracic surgery based on the criteria
in Table 1.

Table 1: Aprotinin Use Criteria
PROPHYLAcnC • USED FOR WGH RISK
OPERATIVE PATIENTS, i.e.
1. Re-do procedures
2. Multiple procedures such as valve and CABG
combination
3. Procedures involving aneurysm repair or resection
4. Procedures with artificial surface implantation
eg. valve conduits, dacron patches, etc.
5. Previous coagulopathy

TIIERAPEt.mC
1. Unanticipated use due to intraoperative
impaired hemostasis eg. aspirin use,
DIC, non-mechanical coagulopathy, etc.
2. Prolonged cardiopulmonary bypass prolonged
= > Shrs of cardiopulmonary bypass
> 3hrs of aortic cross-clamping
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CONVERTING PATIENTS TO DAILY
DOSING SCHEDULE
The committee approved a conversion
formula for patients who are started on
once daily drugs at times other than 9AM,
which is the standard time for giving 'most
once daily medications at LVH. The
formula calls for the second and
subsequent doses to be given at 9AM if the
frrst dose was given prior to midnight. If

the first dose is given after midnight, the
next dose (9AM) is skipped and the
regular schedule started on the following
day. Exceptions to this formula include
amphotericin B, aminoglycosides and
vancomycin, medications ordered at
specific times, and daily meds given at
6PM (digoxin, lovastatin & simvastatin).

TO MONITOR OR NOT TO MONITOR
(VANCO, THAT IS)
The committee reviewed and approved guidelines on the appropriate use of serum
vancomycin monitoring. The guidelines result from a literature review which shows that
vancomycin is only minimally nephrotoxic or ototoxic unless combined with an
aminoglycoside (gentamicin, tobramycin, etc.) This conclusion comes after 36 years of
clinical use of vancomycin. With this in mind, the recommendation is that vancomycin
trough levels may be useful (but are not mandatory) in the following situations:
1. Patients receiving combination therapy with other nephrotoxic agents ie. vancomycin + an aminoglycoside
(gentamicin, tobramycin, or amikacin).
2. Patients on hemodialysis to aid in determining time for next dose (usual adult dose in lGm weekly).
3. Patients being given higher-than-usual doses of vancomycin for resistant or CNS infection.
4. Patients with rapidly changing renal function.

vancomycin serum levels should not be routinely done in patients with normal renal
function and with susceptible organisms. There appears to be no clinical benefit to fmetuning dosages to keep the level of vancomycin exactly within the peak/trough reference
range. The usual adult dose for patients with normal renal function is 15 mg/Kg IV Q12H
or 1 Gm IV Q12H. The pediatric dose is 0.6Gmlm2 IV Q12H.

DRUG USE E.VALUATION (DUE) CORNER
ALTEPLASE
Due to questions regarding therapy complications, the committee began a monthly review of
alteplase (t-PA) use. In April, 5 patients received standard regimen and 2 patients received
accelerated dosing. One patient in the standard therapy group had multiple hematomas which
resolved without intervention.
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GI/COLORECTAL SURGICAL PROPHYLAXIS
This study was performed as a follow up to a similar study performed in April 1993. Cases
were identified from the surgical schedule and included all patients not on antibiotics
preoperatively, without documented signs of infection and/or complications post op. Table 2
shows the results of the findings.
In summary, the fmdings are that the antibiotic was given closer to incision time, and more
appropriate agents were selected, but duration of therapy increased rather than being
reduced to the recommended single dose.

Table 2:

Sun~ical

ProPhylaxis GI/Colorectal Surgery
APRIL 1993

SUMMARY OF
RESULTS
#PATIENTS
#ANALYZED,
EXCLUDING
TREATMENT
CASES
TIME OF DOSE
RELATED TO
INCISION TIME
AGENTS USED

AVERAGE LENGTH
OF SURGICAL
PROPHYLAXIS

APRIL
1994

57

71

51

65

0.5- lH

1-2.5 H
AMPICILLIN/SO
AMP/SB + MNTZ
CEFEZOLIN
CEFAZOLIN + MNTZ
CEFOTETAN
NO ANTIBIOTICS
CIPRO

12
3
18
13
2
8
1

0

MTNTZ

5

0

20.3H

3
0
37
24
1
9

31H

RECOMMENDED
STANDARD

o.. 5- 2 H
GI:CEFAZOLIN
COLO:
CEFAZOUN + MTNZ OR
CEFOTETAN
ALTERN: VANCO (PEN
ALLERGIC)
+1- GENT
SINGLE DOSE

Patients were identified from the daily OR schedule at CC. Charts were reviewed for
surgical procedure performed, antibiotic used for surgical prophylaxis including dose, time
given and duration of therapy. Operative notes, progress notes, and post-op vital signs were
also reviewed for documentation of signs of infection.
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IV DILTIAZEM
The committee reviewed 4 months usage of this agent, which was given conditional approval
in December 1993. The results together with the usage criteria are ih Table 3.
Table 3: Summary of the Results
#PATIENTS RECEIVING IV DILT

26

#PATIENTS RECEMNG IV
VERAPAMIL

40

SCOPE:
26/26 (100%)

# PATIENTS LOCATED IN CRIT
CARE ..
AVERAGE LENGTH OF
THERAPY

47.3H (RANGE 0.5-142.5H)

CRITERIA FOR USE:
INADEQUATE HR CONTROL
POST VERAPAMIL 20MG & lH
INFUSION

2
~

INTOLERANCE TO A 5MG
DOSE VERAPAMIL W/
DECREASE BP

4

BASEUNE SYMPTOMATIC
HYPOTENSION < 90MMHG
REQUIRING PRESSOR AGENTS
OR, EF ~ 35%, &/OR PCWP
2_20MMHG

19
TOTAL:

25/26(96%)

ADVERSE CUNICAL EVENTS:
SYMPTOMATIC HYPOTENSION
< 90MMHG REQUIRING D/C OF
IV DILTIAZEM

)

. 4(15.4%)

96% of the IV diltiazem use was according to the established criteria. The length of
continuous infusion varied from 0.5H to 142.5H. The length of therapy appears to vary per
patient with the optimal infusion length to be determined. The committee approved the
addition of IV diltiazem to the formulary contingent upon the results of a second fo~ month
review of usage.
pt\051494.hi
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